Abstract:Age-related wild-type transthyretin amyloidosis (wtATTR) is characterized by systemic deposition of amyloidogenic fibrils of misfolded transthyretin (TTR) in the connective tissue of many organs. In the heart, this leads to cardiac dysfunction, which is a significant cause of age-related heart failure. The hypothesis tested is that TTR affects cardiac fibroblasts in ways that may contribute to fibrosis. When primary cardiac fibroblasts were cultured on TTR-deposited substrates, the F-actin cytoskeleton was disorganized, focal adhesion formation was decreased, and nuclear shape was flattened. Fibroblasts had faster collective and single-cell migration velocities on TTR-deposited substrates. In addition, fibroblasts cultured on microposts with TTR deposition had reduced attachment and increased proliferation above untreated. Transcriptomic and proteomic analyses of fibroblasts grown on glass covered with TTR showed significant upregulation of inflammatory genes after 48 h, indicative of progression in TTR-based diseases. Together, results suggest that TTR deposited in tissue extracellular matrix may affect the structure, function, and gene expression of cardiac fibroblasts. As therapies for wtATTR are cost-prohibitive and only slow disease progression, better understanding of cellular maladaptation may elucidate novel therapeutic targets.NEW & NOTEWORTHY Transthyretin (TTR) cardiac amyloidosis involves deposition of fibrils of misfolded TTR in the aging human heart, leading to cardiac dysfunction and heart failure. Our novel in vitro studies show that TTR fibrils alter primary cardiac fibroblast cytoskeletal and nuclear structure and focal adhesion formation. Furthermore, both fibrillar and tetrameric TTR significantly increased cellular migration velocity and caused upregulation of inflammatory genes determined by transcriptomic RNA and protein analysis. These findings may suggest new therapeutic approaches.

ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity

ATTRv-V30M Type A amyloid fibrils from heart and nerves exhibit structural homogeneity

ATTRv-V30M Type A amyloid fibrils from the heart and nerves exhibit structural homogeneity.

Multi-organ structural homogeneity of amyloid fibrils in ATTRv-T60A amyloidosis patients, revealed by Cryo-EM

Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy

Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis

Amyloid fibril polymorphism in the heart of an ATTR amyloidosis patient with polyneuropathy attributed to the V122Δ variant

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis

Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients

Clinical and biochemical characterization of asymptomatic carriers and symptomatic patients with hereditary transthyretin amyloidosis caused by TTR V30L mutation

Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition

Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis

Human in vitro disease modeling of ATTR cardiac amyloidosis

Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis

Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis

Transthyretin amyloid fibrils alter primary fibroblast structure, function, and inflammatory gene expression

A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)

Cryo-EM reveals that cardiac IGLV6-derived AL fibrils can be polymorphic

A molecular basis for tetramer destabilization and aggregation of transthyretin Ala97Ser

Detection of ATTR aggregates in plasma of polyneuropathic ATTR-V30M amyloidosis patients

Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis